OMCL stock has delivered an impressive performance in the past year. Shares of the company have risen 47.1% against the industry's 7.9% decline. The S&P 500 composite has increased 18.5% in the said ...

Omnicell delivers strong fourth quarter financial results. Results exceed previously issued full year guidance for bookings, total revenues, and non-GAAP EBITDA. FORT WORTH, Texas ...

Further, Central Pharmacy Dispensing Services continue to gain market traction. Omnicell also offers 340B solutions related to the federal 340B Drug Pricing Program. By combining its 340B TPA ...

Here at Omnicell, we are entering 2025 with a renewed ... automated dispensing systems and the product portion of our central pharmacy dispensing services and IV compounding services as of ...

Another Omnicell medication dispensing robot, the XR2 Automated Central Pharmacy System for oral solvents, increases safety by reducing pharmacist handling of medications through 100 percent bar ...

Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy ...

Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy ...

In addition to its core medication management solutions, Omnicell has been focusing on expanding its presence in the specialty pharmacy market. This strategic initiative is expected to catalyze ...